Drug
Fibrin Sealant Grifols
Fibrin Sealant Grifols: highest development phase Phase 3, developed by Grifols. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Grifols
Trials
| Drug | Phase | Indication |
|---|---|---|
| Fibrin Sealant Grifols NCT01754480 | Phase 3 | Parenchymous Tissue Surgical Bleeding |
Latest
No recent events.
Follow Fibrin Sealant Grifols on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.